Global Vaccine Delivery Devices Market Expected to Deliver Dynamic Progression until 2022

The global vaccine delivery devices market is expected to witness an impressive growth attributed to increasing prevalence of medical infections and diseases. Consumption of vaccine delivery devices is significant in the healthcare industry due to increasing number of diabetic patients globally. Syringes is expected to witness considerable demand among healthcare manufacturers as compared to other vaccine delivery devices in the global market. Intramuscular route is expected to witness more preference as compared to other routes of administration in the global market by the end of 2022. North America is expected to represent the largest market for vaccine delivery devices in the global market throughout 2022.

Vaccine delivery devices is used for treatment of various medical diseases and infections. These are specialized devices that deliver a dose of drug or vaccine through a particular route of administration. Vaccines delivery devices are also increasingly used among diabetic patients to inject doses of insulin such as Novorapid and Lantus.

A recently published report by Fact.MR reveals that the Global Vaccine Delivery Devices Market is expected to register a healthy CAGR, and will represent a value of over US$ 4,000 Mn by the end of 2022.

Consumption in Healthcare Industry

Apart from injecting anesthesia before beginning with an operation, the vaccine delivery devices extend their application for various treatments in the healthcare industry. Healthcare professionals increasingly use vaccine delivery devices to inject medications in order to prevent prevalence of infections and diseases. According to the centers for disease control and prevention (CDC), vaccination should be given during the period of birth and adulthood in order to maintain lifetime protection from several infections and diseases including influenza, meningitis, and hepatitis A and B.

Considerable Demand among Diabetic Patients

As diabetes type 1 and 2 have been increasingly prevalent among the geriatric population, vaccine delivery devices has been witnessing an upsurge in demand in the healthcare industry. Healthcare professionals recommend patients who have brittle diabetes to inject certain doses of insulin such as Novorapid and Lantus regularly. Such factors have fuelled demand for vaccine delivery devices among the healthcare manufacturers.

Manufacturers are integrating developing technologies available in the market in order to offer vaccine delivery devices that are comparatively less painful. A recent news update reveals that a new device has been developed ‘Microneedle Patches’, which is a needle-free injector and can inject a vaccine doze in a fraction of second. Bound to such factors, the global vaccine delivery devices market is expected witness a boost in growth during the predicted period.

Intramuscular Vaccine to Register Significant Growth

Syringes is expected to witness the highest revenue growth in the global vaccine delivery devices market. This segment is expected to represent a value of over US$ 900 Mn in the global market by the end of 2017. North America is expected to remain the largest market for vaccine delivery devices globally. Jet devices is expected to witness the second highest revenue growth in 2017. Throughout 2022, syringes is expected to register the highest CAGR growth as compared to other products in the global market, followed by jet devices.

Intramuscular vaccine route of administration is expected to register the highest CAGR growth in the global vaccine delivery devices market, followed by subcutaneous route of administration. The intramuscular vaccine route of administration is expected to witness the highest revenue growth in the global market. This segment is expected to represent a value of over US$ 1,000 Mn by the end of 2022. Subcutaneous route of administration is expected to represent the second highest revenue growth in the global vaccine delivery devices market during the predicted period.

Competition Tracking

Key market players operating in the global vaccine delivery devices market include Becton Dickinson & Company, PharmaJet, Inc, Valeritas Holdings, Inc, Vaxxas Pty. Ltd, Gerresheimer AG, Schott AG, Antares Pharma, Inc, and 3M Company.



Reset Password